Oxymorphone Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0115-1317

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 0115-1317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxymorphone Hydrochloride Extended Release Tablets 1)

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

FDA Label Image

Figure 1 (Oxymorphone Hydrochloride Extended Release Tablets 2)

FDA Label Image

Figure 2 (Oxymorphone Hydrochloride Extended Release Tablets 3)

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

This is a medication label for twice-daily extended-release tablets of oxymorphone hydrochloride, 5 mg strength. The NDC code is 0115-1231-01, and the prescription is only available to be dispensed by a pharmacist. Patients should receive the medication guide along with the 100 tablets. The remaining text appears to be a mix of random alphanumeric characters and is not relevant to the medication description.*

FDA Label Image

Principal Display Panel (7.5 mg Tablet Bottle Label)

This is a prescription medicine called Oxymorphone Hydrochloride (7.5mg, Extended-Release Tablets, USP). The medication needs to be taken twice a day, 12 hours apart. The NDC number for this medication is 0115-1315-01. The medicine comes in a package that has 100 tablets. If you are a pharmacist, it is important to dispense the medication guide to each patient.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

This is a description of the prescription drug Oxymorphone Hydrochloride Extended-Release tablets, with an NDC number of 0115-1232-01 and a strength of 10 mg. The suggested dosage is twice daily, every 12 hours. The text includes a warning to pharmacists to dispense the Medication Guide to each patient. The rest of the text appears to be gibberish or nonsense characters and is not relevant to the drug's description.*

FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

This is a prescription drug information sheet for Oxymorphone Hydrochloride Extended-Release Tablets. Each bottle has 100 Tablets with a strength of 20mg, and should be taken twice a day, every 12 hours. The unique NDC number for this drug is 0115-1233-01. The package should have a Medication Guide leaflet for patients. Any other information is not readable due to errors.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

This is a prescription medication, NDC 0115-1317-01. The tablets contain 30 mg of extended-release Oxymorphone hydrochloride. The suggested dosage is twice a day, every 12 hours. The pharmacist is advised to dispense the medication guide to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.